Non-Responsive Celiac Disease (NRCD)

Definition

  • Persistent symptoms, signs despite 6-12 months dietary gluten avoidance.
  • Abnormal tissue transglutaminase (tTG) persists 2-3 years.

Etiology And Differential Diagnosis

CategoryAssociated Conditions
Primary FactorOngoing inadvertent gluten ingestion.
Alternate Villous Atrophy CausesAutoimmune enteropathy, tropical sprue, medication-induced enteropathy, hypogammaglobulinemia, combined variable immunodeficiency, collagenous sprue, Crohn disease, peptic duodenitis.
Celiac-Like Presentations (No Villous Atrophy)Irritable bowel syndrome (IBS), carbohydrate malabsorption, small intestinal bacterial overgrowth, microscopic colitis.
Additional PathologiesCow milk protein allergic enteropathy, pancreatic insufficiency.

Diagnostic Evaluation

  • Confirm accuracy of initial celiac disease diagnosis.
  • Verify small bowel histology findings consistent with celiac disease.
  • Document positive endomysial antibody (EMA), tTG, or deamidated gliadin peptide (DGP) serology during clinical course.
  • Confirm presence of human leukocyte antigen (HLA)-DQ2 or HLA-DQ8.
  • Note presence of biopsy-proven dermatitis herpetiformis, strong family history, or associated autoimmune disorders.
  • Perform expert dietitian evaluation.
  • Check celiac serologies; positive testing despite 12 months on gluten-free diet (GFD) indicates ongoing gluten ingestion.
  • Obtain small bowel biopsy.
  • Add colonic biopsies for persistent diarrhea.

Management

  • Implement rigorously supervised strict GFD to resolve ongoing ingestion.
  • Adjust diet, monitor progress.
  • Treat identified alternative etiologies for ongoing symptoms.

Refractory Celiac Disease (RCD)

Definition And Characteristics

  • Persistent, recurrent malabsorptive symptoms, signs.
  • Small intestinal villous atrophy present despite strict GFD >12 months.
  • Absence of other disorders, overt lymphoma.
  • Rare occurrence; scarce evidence for pediatric existence.
  • Primarily diagnosed in adults.

Classification

  • Subdivided according to intraepithelial lymphocyte (IEL) phenotype.
  • Type I RCD: Normal IEL phenotype.
  • Type II RCD: Abnormal, clonal intestinal T lymphocytes.
  • Type II RCD considered low-grade intraepithelial lymphoma.
  • Type II RCD carries poor prognosis.

Pathophysiology And Diagnosis

  • Rigorously exclude other NRCD causes (Crohn disease, autoimmune enteropathy, small bowel bacterial overgrowth, cow milk protein allergy, pancreatic insufficiency) before confirming true RCD.
  • Identify abnormal intestinal lymphocytes via immunohistochemistry of IELs.
  • Utilize flow cytometry demonstrating increased CD3-positive cells lacking CD8.
  • Identify clonal T-cell receptor gene rearrangement via molecular analysis.